4-benzyl-2-(2-chloroethyl)morpholine | 122894-54-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-benzyl-2-(2-chloroethyl)morpholine
• 英文别名: 2-(2-chloroethyl)-4-(phenylmethyl)morpholine；2-(2-chloroethyl)-4-benzylmorpholine
• CAS: 122894-54-6
• 化学式: C₁₃H₁₈ClNO
• 分子量: 239.745
• InChiKey: LIEUHQQEZPQUMC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-benzyl-2-(2-chloroethyl)morpholine 在 一水合肼 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 9.0h， 生成 2-(2-aminoethyl)-4-benzylmorpholine
  参考文献：
  名称：

  Quinolone antimicrobial agents substituted with morpholines at the 7-position. Syntheses and structure-activity relationships

  摘要：

  A series of novel 7-substituted 1-cyclopropyl-6,8-difluoro- 1,4-dihydro-4-oxo-3-quinolinecarboxylic acids have been prepared and tested for antibacterial activities and for convulsive activities in combination with nonsteroidal antiinflammatory drug. Structure-activity relationships revealed that 7-(2-(aminomethyl)morpholino) derivative 28 had a better Gram-positive activity than the reference quinolones, such as ciprofloxacin, norfloxacin, and ofloxacin. Its Gram-negative activity was equipotent with those of norfloxacin and ofloxacin but was inferior to that of ciprofloxacin. In mouse systemic infection models, 28 showed an excellent therapeutic efficacy which might result from the potent antibacterial activity and suitable physicochemical properties. Convulsive activities of 7-morpholino derivatives in combination with nonsteroidal antiinflammatory drug fenbufen or its metabolite biphenylacetic acid markedly diminished as compared to those of 7-piperazino derivatives in the electrophysiological, biochemical, and behavioral experiments. These results suggest that 28 (Y-26611) is a novel quinolone with reduced neurotoxic excitatory adverse reaction.

  DOI：

  10.1021/jm00062a007
• 作为产物：
  描述：

  4-苄基-2-(2-羟基乙基)吗啉 在 氯化亚砜 作用下， 以 氯仿 、 水 为溶剂， 生成 4-benzyl-2-(2-chloroethyl)morpholine
  参考文献：
  名称：

  Quinolonecarboxylic acid compounds and pharmaceutical use thereof

  摘要：

  一种喹诺酮羧酸化合物，其结构式如上：##STR1##其中，R1为烷基、环烷基、卤代烷基、烯基、单或双烷基氨基、苯基或被一个至三个选自卤素、烷基、烷氧基、羟基、硝基或氨基的取代基取代的苯基；R2为氢、烷基、环烷基、酰基或烷氧羰基；R3为氢、烷基或芳烷基，或者R2和R3与相邻的氮原子一起形成杂环；R4为氢或烷基；R5为氢、烷基、芳烷基或体内易水解的酯残基；X为氢、卤素或烷基；n为1至3的整数；及其盐，以及其在医药上的用途。这些化合物具有抗菌活性，可用于治疗各种感染性疾病。

  公开号：

  US04889857A1

文献信息

• Antipicorpaviral herterocyclic-substituted morpholinyl alkylphenol ethers
  申请人：Janssen Pharmaceutica N.V.

  公开号：US05070090A1

  公开（公告）日：1991-12-03

  Novel (thio)morpholinyl and piperazinyl alkylphenol ethers having antirhinoviral activity, compositions containing these compounds as active ingredient, and a method of inhibiting, combating or preventing the growth of viruses in warm-blooded animals suffering from diseases caused by these viruses.

  新型（硫）吗啉基和哌嗪基烷基酚醚具有抗鼻病毒活性，含有这些化合物作为活性成分的组合物，以及一种抑制、对抗或预防患有由这些病毒引起的疾病的温血动物体内病毒生长的方法。
• Antirhinoviral (thio)morpholinyl and piperazinyl alkylphenol ethers
  申请人：JANSSEN PHARMACEUTICA N.V.

  公开号：EP0398426A1

  公开（公告）日：1990-11-22

  (Thio)morpholinyl and piperazinyl alkylphenol ethers of formula X is O, S or NR⁵; n is 1 to 4; R¹ and R² are hydrogen, C₁₋₄alkyl or halo; and R³ is hydrogen, halo, cyano, C₁₋₄alkyloxy, aryl or -COOR⁴ with R⁴ being hydrogen, C₁₋₄alkyl, arylC₁₋₄alkyl, C₃₋₆cycloalkylC₁₋₄alkyl, C₃₋₅alkenyl, C₃₋₅alkynyl or C₁₋₄alkyloxyC₁₋₄alkyl; or R³ is a radical of formula the acid addition salts and stereochemically isomeric forms thereof, said compounds having antirhinoviral activity, pharmaceutical compositions containing these compounds as active ingredient, and a method of preparing said compounds and pharmaceutical compositions.

  (硫)吗啉基和哌嗪基烷基酚醚，式中 X 是 O、S 或 NR⁵；n 是 1 至 4；R¹ 和 R² 是氢、C₁₋₄烷基或卤素；和 R³ 是氢、卤素、氰基、C₁₋₄烷氧基、芳基或 -COOR⁴，其中 R⁴ 是氢、C₁₋₄烷基、芳基、C₃₋₆环烷基、C₁₋₄烷基、C₃₋₅烷氧基或 C₁₋₄烷₁₋₄；或 R³ 是式中的基团 其酸加成盐和立体化学异构体形式，所述化合物具有抗鼻炎病毒活性，含有这些化合物作为活性成分的药物组合物，以及制备所述化合物和药物组合物的方法。
• ARAKI, KAZUHIKO;KURODA, TSUYOSHI;UEMORI, SATORU;MORIGUCHI, AKIHIKO;IKEDA,+
  作者：ARAKI, KAZUHIKO、KURODA, TSUYOSHI、UEMORI, SATORU、MORIGUCHI, AKIHIKO、IKEDA,+

  DOI：——

  日期：——
• US4889857A
  申请人：——

  公开号：US4889857A

  公开（公告）日：1989-12-26
• US5070090A
  申请人：——

  公开号：US5070090A

  公开（公告）日：1991-12-03